These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15073939)

  • 21. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
    Tohen M; Frank E; Bowden CL; Colom F; Ghaemi SN; Yatham LN; Malhi GS; Calabrese JR; Nolen WA; Vieta E; Kapczinski F; Goodwin GM; Suppes T; Sachs GS; Chengappa KR; Grunze H; Mitchell PB; Kanba S; Berk M
    Bipolar Disord; 2009 Aug; 11(5):453-73. PubMed ID: 19624385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions.
    Alecu I; Bousquet C; Mougin F; Jaulent MC
    Stud Health Technol Inform; 2006; 124():833-8. PubMed ID: 17108616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions reporting at a referral hospital in Zimbabwe.
    Khoza S; Madungwe I; Nyambayo P; Mthethwa J; Chikuni O
    Cent Afr J Med; 2004; 50(11-12):104-7. PubMed ID: 16615658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa).
    Jacobs I; Nadkarni V; Bahr J; Berg RA; Billi JE; Bossaert L; Cassan P; Coovadia A; D'Este K; Finn J; Halperin H; Handley A; Herlitz J; Hickey R; Idris A; Kloeck W; Larkin GL; Mancini ME; Mason P; Mears G; Monsieurs K; Montgomery W; Morley P; Nichol G; Nolan J; Okada K; Perlman J; Shuster M; Steen PA; Sterz F; Tibballs J; Timerman S; Truitt T; Zideman D; ; ; ; ; ; ; ; ;
    Circulation; 2004 Nov; 110(21):3385-97. PubMed ID: 15557386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontological representation of adverse drug reactions using the Foundational Model of Anatomy.
    Bousquet C; Gasperina P; Trombert B; Clavel L; Kumar A; Rodrigues JM
    Stud Health Technol Inform; 2009; 150():507-11. PubMed ID: 19745363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries. A statement for healthcare professionals from a task force of the international liaison committee on resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa).
    Jacobs I; Nadkarni V; Bahr J; Berg RA; Billi JE; Bossaert L; Cassan P; Coovadia A; D'Este K; Finn J; Halperin H; Handley A; Herlitz J; Hickey R; Idris A; Kloeck W; Larkin GL; Mancini ME; Mason P; Mears G; Monsieurs K; Montgomery W; Morley P; Nichol G; Nolan J; Okada K; Perlman J; Shuster M; Steen PA; Sterz F; Tibballs J; Timerman S; Truitt T; Zideman D;
    Resuscitation; 2004 Dec; 63(3):233-49. PubMed ID: 15582757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding.
    Fraser IS; Critchley HO; Munro MG; Broder M;
    Fertil Steril; 2007 Mar; 87(3):466-76. PubMed ID: 17362717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
    Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hand-arm vibration syndrome and upper limb disorders associated with forestry work].
    Bovenzi M; Rui F; Versini W; Tommasini M; Nataletti P
    Med Lav; 2004; 95(4):282-96. PubMed ID: 15532961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
    Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
    Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of an electronic medical record system for mandatory reporting of drug hypersensitivity reactions has been shown to improve the management of patients in the university hospital in Korea.
    Park CS; Kim TB; Kim SL; Kim JY; Yang KA; Bae YJ; Cho YS; Moon HB
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):919-25. PubMed ID: 18470952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
    Geier MR; Geier DA
    Hepatogastroenterology; 2004; 51(57):762-7. PubMed ID: 15143911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.